CRISPR AND CAS GENE MARKET ANALYSIS

Crispr and Cas Gene Market, By Product Type (Vector-based Cas, DNA-free Cas, and Others), By Application (Genome Engineering, Disease Models, Functional Genomics, Knockdown/Activation, and Others), By End User (Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023
Code : CMI2598
Pages :165
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Crispr and Cas Gene Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global crispr and cas gene market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2023. Global crispr and cas gene market is expected to witness significant growth in the near future, driven by increasing research and development in the field by the market players. For instance, on March 21, 2022, Merck KGaA, a pharmaceutical company, signed a collaboration and license agreement with an Israeli AgTech company to demonstrate the utility of its proprietary CRISPR genome-editing tools.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa